Sep. 21, 2026
Since 2012, medical gas pipeline systems have primarily adhered to the GB 50751-2012 standard. As a mandatory national standard for engineering construction, it effectively addressed issues such as inconsistent design, material selection, and construction quality across hospitals, as well as chaotic gas supply configurations and installation practices; it significantly reduced safety hazards like system leaks, unstable gas supply, and cross-contamination of gases. However, because it focused solely on the project construction phase, there was a lack of standards regarding equipment manufacturing, registration management, and system operation and maintenance.
The GB/T 44059.1-2024 standard, set to take effect in July 2025, achieves a major regulatory breakthrough. It explicitly classifies medical gas pipeline systems as Class II medical devices under the jurisdiction of the National Medical Products Administration (NMPA). It mandates product registration and requires enterprises to obtain licenses for medical device manufacturing and distribution, thereby addressing regulatory gaps on the manufacturing side.
It is important to note that GB/T 44059.1-2024 and GB 50751-2012 will coexist and complement each other rather than replace one another.
The implementation of this new standard targets core issues currently facing the industry, specifically:
• Regulatory Misalignment: GB 50751-2012 was overseen by housing and urban-rural development authorities, focusing only on design, construction, and acceptance. It did not cover manufacturing or post-installation operation and maintenance, nor did it require medical device registration or licensing; consequently, tracing the root cause of safety incidents was extremely difficult.
• Gap in Technical Standards Compared to International Levels: There were discrepancies between domestic practices—such as gas source configuration and piping material requirements—and advanced international standards. Examples include the lack of unified specifications for alarm systems, requirements for only three-source backup for oxygen, and permission to use non-copper materials for low-pressure vacuum piping.
• Fragmented Industry Landscape: While the domestic medical gas market has grown rapidly, the industry consists largely of small and medium-sized enterprises. Price-based competition is widespread, and market concentration remains low.
• Insufficient Intelligence: Most hospitals still rely on manual methods for equipment inspections, resulting in weak risk management capabilities.
The implementation of GB/T 44059.1-2024 signifies that the standards for medical gas pipeline systems have expanded beyond the regulation of engineering construction to include the full lifecycle management of medical devices, thereby addressing regulatory gaps at the manufacturing stage.
1.Restructuring of the Regulatory System: The National Medical Products Administration (NMPA) has become the primary regulatory authority. As the products are classified as Class II medical devices, they require specific product registration, and enterprises must hold the necessary licenses for the production and distribution of medical devices. The scope of regulation covers the entire process—from design, production, installation, and usage to operation, maintenance, and eventual decommissioning.
2.Comprehensive Upgrade of Technical Requirements: Stricter requirements have been established for gas source configuration, gas quality, post-treatment, valves, and alarm systems.
• Comprehensive Upgrade of Gas Source Configuration: It is mandatory for compressed medical gas and vacuum systems to have at least three independent supply sources (primary, secondary, and backup), with each source capable of independently meeting the system's design flow rate, thereby completely eliminating the risk of single-point failure.
• Higher Standards for Gas Quality and Post-treatment: Requirements for the moisture content of medical air have been tightened (specifying a dew point of -46°C). If oil-lubricated compressors are used, post-treatment equipment—such as multi-stage filters—must be installed.
• Refined Requirements for Zone Valves and Alarm Systems: Zone valve boxes must adhere to a "one box, one gas" principle and be equipped with downstream inlet points for emergency use and maintenance. Alarm systems are strictly categorized into operational, emergency operational, and emergency clinical alarms, and must comply with the YY 9706.108 standard for medical device alarms.
• Piping Materials and Construction Specifications: Copper piping is designated as the preferred material for all medical gas pipelines; furthermore, continuous purging with an inert gas (such as nitrogen) is required during brazing to ensure the internal cleanliness of the pipes
3.Driving Industrial Evolution: Higher market entry barriers compel enterprises to invest in technological R&D and phase out non-compliant or outdated companies. This shifts the industry from fragmented competition toward consolidation and standardization, fostering a "product plus service" full-lifecycle business model.
China is currently implementing its 15th Five-Year Plan. Against the backdrop of the "15th Five-Year Plan," the focus of development is shifting toward high-quality growth and the cultivation of "new quality productive forces," while continuously advancing the "Digital China" initiative and the green transformation of society. Consequently, the medical gas pipeline system sector must keep pace with the times and align with new industry requirements.
1.Comprehensive Compliance and Full-Chain Traceability: Enterprises must establish traceability systems covering the entire chain—from factory production and transport/distribution to end-use—moving away from crude operational models.
2.Intelligence and Digital Infrastructure: Leveraging the Internet of Things (IoT), cloud computing, and big data to build a "digital foundation" for pipeline networks. By deploying intelligent monitoring terminals, the industry can achieve 24-hour real-time data collection, automatic early warning, and remote control, shifting operations and maintenance from "reactive response" to "proactive prevention.
3.Industry Ecosystem Integration: The sector needs to transition from isolated equipment manufacturing or engineering installation to an integrated, full-lifecycle model encompassing "production, storage and transport, equipment integration, and O&M services." Enterprises capable of providing full-chain services will gain a competitive advantage.
1.Deep Intelligence: IoT and predictive maintenance will become mainstream, with medical gas systems deeply integrated into hospital information systems
2.Continuous Standardization: Subsequent standards in the GB/T 44059 series will be released, establishing a regulatory network that covers the entire industry chain.
3.Industry Restructuring: Market concentration will rise, and full-lifecycle service capabilities will become a core competitive advantage, ensuring patient safety regarding gas usage and driving the global expansion of domestic medical equipment.
4.High-End Technology and Accelerated Localization: R&D focus will shift toward ultra-high-purity specialty medical gases and mixed-ratio gases. Simultaneously, domestic enterprises will accelerate breakthroughs against imported technology barriers, significantly speeding up the process of domestic substitution.
Significant Increase in Industry Concentration: Driven by the dual pressures of rising compliance costs and rapid technological iteration, inefficient production capacity will be phased out, and market share will consolidate among leading enterprises that possess sufficient scale and robust compliance systems.

Sep. 21, 2026
+86 139 1038 2839
medioxy@can-gas.comB514~516, GID International Center, 27 Nanbinhe Road, Xicheng District, Beijing, China, 100055.
Copyright @ CAN GAS SYSTEMS COMPANY LIMITED All Rights Reserved | Sitemap |
Powered by 